Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.0010 USD
Change Today -0.0002 / -16.67%
Volume 90.9K
As of 8:10 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

kiwa bio-tech products group (KWBT) Snapshot

Previous Close
Day High
Day Low
52 Week High
03/13/15 - $0.0030
52 Week Low
06/5/15 - $0.0001
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

kiwa bio-tech products group (KWBT) Related Businessweek News

No Related Businessweek News Found

kiwa bio-tech products group (KWBT) Details

Kiwa Bio-Tech Products Group Corporation, through its subsidiaries, focuses on developing, manufacturing, distribution, and marketing bio-technological products for the agriculture markets primarily in the People’s Republic of China. It has technologies to produce and market bio-fertilizers. The company was founded in 2002 and is based in Claremont, California.

8 Employees
Last Reported Date: 06/29/15
Founded in 2002

kiwa bio-tech products group (KWBT) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

kiwa bio-tech products group (KWBT) Key Developments

Kiwa Bio-Tech Products Group Corporation Announces Executive Changes

On July 1, 2015, Mr. Wei Li resigned as President, Chief Executive Officer and Chief Operating Officer and Mr. Steven Ning Ma resigned as Chief Financial Officer of Kiwa Bio-Tech Products Group Corporation. To the knowledge of the Company's executive officers, the resignations of Mr. Li and Mr. Ma are not the result of any disagreement with the Company on any matter related to the Company's operations, policies or practices. Effective as of July 1, 2015 upon the resignations of Mr. LI and Mr. Ma, the Company appointed Mr. Jimmy Ji Zhou as the Company's President, Chief Executive officer and interim Chief Financial Officer. Mr. Zhou was employed by AXA Advisors LLC ("AXA") in California as a financial advisor from 2000 to 2007. He became a Certified Estate Planner (CEP) and a Registered Financial Consultant (RFC) with AXA in 2005.

Kiwa Bio-Tech Products Group Corporation Auditor Raises 'Going Concern' Doubt

Kiwa Bio-Tech Products Group Corporation filed its 10-K on Jun 29, 2015 for the period ending Dec 31, 2014. In this report its auditor, Paritz & Company, P.A., gave an unqualified opinion expressing doubt that the company can continue as a going concern.

Kiwa Bio-Tech Products Group Corporation announced delayed annual 10-K filing

On 03/30/2015, Kiwa Bio-Tech Products Group Corporation announced that they will be unable to file their next 10-K by the deadline required by the SEC.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
KWBT:US $0.00 USD -0.0002

KWBT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for KWBT.
View Industry Companies

Industry Analysis


Industry Average

Valuation KWBT Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KIWA BIO-TECH PRODUCTS GROUP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at